Brief: Rovi Maintains Its 2025 Guidance

Laboratorios Farmaceuticos Rovi

25/02/2025 06:49

Feb 25 (Reuters) - Laboratorios Farmaceuticos ROVI SA
 ROVI.MC :
    * MAINTAINS ITS PREVIOUSLY ANNOUNCED 2025 GUIDANCE

Source text:  ID:nCNM5k0s8x 
Further company coverage:  ROVI.MC 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))